Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?

Autor: P, Tarantino, H J, Burstein, N U, Lin, I E, Krop, E P, Winer, S J, Schnitt, E P, Hamilton, S A, Hurvitz, H S, Rugo, G, Curigliano, S M, Tolaney

Publikováno v: Annals of Oncology. 33:234-238

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::729b79003b8702847496928fa1713e91
https://doi.org/10.1016/j.annonc.2021.12.004

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

Autor: F, CARDOSO, Paluch-Shimon, S, Senkus, E, Curigliano, G, Aapro, M S, F, ANDE, C H, BARRIOS, J, BERGH, Bhattacharyya, G S, Biganzoli, L, F, BOYLE, CARDOSO, M-J, L A, CAREY, J, CORTES, EL SAGHIR, N S, M, ELZAYAT, A, ENIU, L, FALLOWFIED, P A, FRANCIS, Gelmon, K, Gligorov, J, R, HAIDINGER, Harbeck, N, X, HU, Kaufman, B, Kaur, R., B E, KIELY, S-B, KIM, N U, LIN, S A, MERTZ, S, NECIOSUP, Offersen, BV, S, OHNO, O, PAGANI, A, PRAT, Penault-Llorca, F, Rugo, HS, Sledge, GW, Thomssen, C, Vorobiof, DA, Wiseman, T., B, XU, Norton, L, A, COSTA, Winer, EP

Publikováno v: Annals of Oncology
Annals of Oncology, Elsevier, 2020, 31 (12), pp.1623-1649. ⟨10.1016/j.annonc.2020.09.010⟩
Cardoso, F, Paluch-Shimon, S, Senkus, E, Curigliano, G, Aapro, M S, André, F, Barrios, C H, Bergh, J, Bhattacharyya, G S, Biganzoli, L, Boyle, F, Cardoso, M J, Carey, L A, Cortés, J, El Saghir, N S, Elzayat, M, Eniu, A, Fallowfield, L, Francis, P A, Gelmon, K, Gligorov, J, Haidinger, R, Harbeck, N, Hu, X, Kaufman, B, Kaur, R, Kiely, B E, Kim, S B, Lin, N U, Mertz, S A, Neciosup, S, Offersen, B V, Ohno, S, Pagani, O, Prat, A, Penault-Llorca, F, Rugo, H S, Sledge, G W, Thomssen, C, Vorobiof, D A, Wiseman, T, Xu, B, Norton, L, Costa, A & Winer, E P 2020, ' 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) ', Annals of Oncology, vol. 31, no. 12, pp. 1623-1649 . https://doi.org/10.1016/j.annonc.2020.09.010

Highlights • This ESO-ESMO ABC 5 Clinical Practice Guideline provides key recommendations for managing advanced breast cancer patients • It provides updates on the management of patients with all breast cancer subtypes, LABC, follow-up, palliativ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f447f637b8d6a6be076b5f2f20fdd73f
https://hal.archives-ouvertes.fr/hal-03046234

A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets

Autor: N. U. Lin

Publikováno v: Journal of Clinical Endocrinology & Metabolism. 81:2564-2569

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2fcdf8d316087c5fdf08c0f51869dcae
https://doi.org/10.1210/jc.81.7.2564

HER2 suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LPT112515)

Autor: N. U. Lin, M. A. Danso, A. K. David, J. J. Muscato, C. E. Ellis, S. Lahiri, T. Sessa, Y. M. Nagarwala, E. Winer

Publikováno v: Journal of Clinical Oncology. 29:TPS113-TPS113

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3360a198628666ec180a1448523a5b4
https://doi.org/10.1200/jco.2011.29.15_suppl.tps113